Authors:
LI XM
METZGER G
FILIPSKI E
LEMAIGRE G
LEVI F
Citation: Xm. Li et al., MODULATION OF NONPROTEIN SULFHYDRYL COMPOUNDS RHYTHM WITH BUTHIONINE SULFOXIMINE - RELATIONSHIP WITH OXALIPLATIN TOXICITY IN MICE, Archives of toxicology, 72(9), 1998, pp. 574-579
Citation: P. Depresbrummer et al., PHARMACOLOGICAL RESTORATION OF SUPPRESSED TEMPERATURE RHYTHMS IN RATSBY MELATONIN, MELATONIN RECEPTOR AGONIST, S20242, OR 8-OH-DPAT, European journal of pharmacology, 347(1), 1998, pp. 57-66
Authors:
WILDFEUER A
NEU IS
SAFAYHI H
METZGER G
WEHRMANN M
VOGEL U
AMMON HPT
Citation: A. Wildfeuer et al., EFFECTS OF BOSWELLIC ACIDS EXTRACTED FROM A HERBAL MEDICINE ON THE BIOSYNTHESIS OF LEUKOTRIENES AND THE COURSE OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS, Arzneimittel-Forschung, 48(6), 1998, pp. 668-674
Citation: G. Metzger et Xp. Hu, APPLICATION OF INTERLACED FOURIER-TRANSFORM TO ECHO-PLANAR SPECTROSCOPIC IMAGING, Journal of magnetic resonance [1997], 125(1), 1997, pp. 166-170
Authors:
DEPRESBRUMMER P
BOURIN P
PAGES N
METZGER G
LEVI F
Citation: P. Depresbrummer et al., PERSISTENT T-LYMPHOCYTE RHYTHMS DESPITE SUPPRESSED CIRCADIAN CLOCK OUTPUTS IN RATS, American journal of physiology. Regulatory, integrative and comparative physiology, 42(6), 1997, pp. 1891-1899
Citation: F. Levi et al., CHRONOTHERAPY WITH 5-FLUOROURACIL, OXALIPLATIN, AND FOLINIC ACID IN COLORECTAL-CANCER - REPLY, Lancet, 350(9087), 1997, pp. 1326-1326
Authors:
LI XM
METZGER G
FILIPSKI E
BOUGHATTAS N
LEMAIGRE G
HECQUET B
FILIPSKI J
LEVI F
Citation: Xm. Li et al., PHARMACOLOGICAL MODULATION OF REDUCED GLUTATHIONE CIRCADIAN-RHYTHMS WITH BUTHIONINE SULFOXIMINE - RELATIONSHIP WITH CISPLATIN TOXICITY IN MICE, Toxicology and applied pharmacology, 143(2), 1997, pp. 281-290
Authors:
MACHOVER D
DIAZRUBIO E
DEGRAMONT A
SCHILF A
GASTIABURU JJ
BRIENZA S
ITZHAKI M
METZGER G
NDAW D
VIGNOUD J
ABAD A
FRANCOIS E
GAMELIN E
MARTY M
SASTRE J
SEITZ JF
YCHOU M
Citation: D. Machover et al., 2 CONSECUTIVE PHASE-II STUDIES OF OXALIPLATIN (L-OHP) FOR TREATMENT OF PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA WHO WERE RESISTANT TO PREVIOUS TREATMENT WITH FLUOROPYRIMIDINES, Annals of oncology, 7(1), 1996, pp. 95-98
Authors:
DEPRESBRUMMER P
METZGER G
MORIN D
URIEN S
TOUITOU Y
TILLEMENT JP
CLAUSTRAT B
LEVI F
Citation: P. Depresbrummer et al., PHARMACOKINETICALLY GUIDED MELATONIN SCHEDULING IN RATS WITH CIRCADIAN SYSTEM SUPPRESSION, European journal of pharmacology, 312(2), 1996, pp. 171-178
Authors:
LEVI F
GIACCHETTI S
ADAM R
ZIDANI R
METZGER G
MISSET JL
Citation: F. Levi et al., CHRONOMODULATION OF CHEMOTHERAPY AGAINST METASTATIC COLORECTAL-CANCER, European journal of cancer, 31A(7-8), 1995, pp. 1264-1270
Authors:
DEPRESBRUMMER P
LEVI F
METZGER G
TOUITOU Y
Citation: P. Depresbrummer et al., LIGHT-INDUCED SUPPRESSION OF THE RAT CIRCADIAN SYSTEM, American journal of physiology. Regulatory, integrative and comparative physiology, 37(5), 1995, pp. 1111-1116
Authors:
DEPRESBRUMMER P
METZGER G
LARUEACHAGIOTIS C
TOUITOU Y
LEVI F
Citation: P. Depresbrummer et al., PROLONGED EXPOSURE OF RATS TO CONSTANT LIGHT - AN ANIMAL-MODEL OF ENVIRONMENTALLY-INDUCED FUNCTIONAL SUPPRESSION OF THE CIRCADIAN SYSTEM, Biological rhythm research, 25(2), 1994, pp. 213-215
Authors:
LEVI F
TAMPELLINI M
METZGER G
BIZI E
LEMAIGRE G
HALLEK M
Citation: F. Levi et al., CIRCADIAN CHANGES IN MITOXANTRONE TOXICITY IN MICE - RELATIONSHIP WITH PLASMA PHARMACOKINETICS, International journal of cancer, 59(4), 1994, pp. 543-547
Authors:
METZGER G
MASSARI C
ETIENNE MC
COMISSO M
BRIENZA S
TOUITOU Y
MILANO G
BASTIAN G
MISSET JL
LEVI F
Citation: G. Metzger et al., SPONTANEOUS OR IMPOSED CIRCADIAN CHANGES IN PLASMA-CONCENTRATIONS OF 5-FLUOROURACIL COADMINISTERED WITH FOLINIC ACID AND OXALIPLATIN - RELATIONSHIP WITH MUCOSAL TOXICITY IN PATIENTS WITH CANCER, Clinical pharmacology and therapeutics, 56(2), 1994, pp. 190-201
Authors:
MACHOVER D
GRISON X
GOLDSCHMIDT E
ZITTOUN J
METZGER G
RICHAUD J
LOTZ JP
ANDRE T
HANNOUN L
MARQUET J
GUILLOT T
BARDON M
SALMON R
SEZEUR A
MAUBAN S
IZRAEL V
PARC R
Citation: D. Machover et al., 5-FLUOROURACIL COMBINED WITH THE [6S]-STEREOISOMER OF FOLINIC ACID INHIGH-DOSES FOR TREATMENT OF PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA - A PHASE-I-II STUDY OF 2 CONSECUTIVE REGIMENS, Annals of oncology, 4, 1993, pp. 190000029-190000035